In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022. Purchasing power in the country is expected to fell nearly by 2.5%.
On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.
· On April 23, 2o19, Boston Scientific Corporation announced that it received the FDA approval for its LOTUS Edge™ Aortic Valve System. It is a form of trans-catheter aortic valve replacement (TAVR) technology that is delivered through a minimally invasive technique.
· On September 27, 2019, Abbott announced the approval of its two pediatric devices for congenital heart defects in Europe. The devices named Masters HP™ 15mm rotatable mechanical heart valve and Amplatzer Piccolo™ Occluder have received the CE Mark and are available in the regions recognizing this mark. The Masters valve is the world’s smallest mechanical heart valve which allows the replacement of mitral or aortic valve in infants. On the other hand, the Amplatzer Piccolo is used to treat patent ductus arteriosus (PDA) and can be used for babies weighing under one kilogram.
Structural heart diseases are the heart defects caused as a result of problems with the heart valves or the cardiac tissues. Several structural heart diseases are present at birth and known as congenital heart diseases. Others might develop at later stages of life. The various structural heart disease range from cardiomyopathy, which affects the heart muscles, to mitral valve regurgitation where the blood leaks in the backward direction from the mitral valve. In order to treat these disorders, structural heart devices are required which either repair the problem or replace the defective part or tissue of the heart. The market for structural heart devices is projected to witness a significantly high growth in the upcoming years on account of these diseases.
The Centers for Disease Control and Prevention estimated through a study in Atlanta that around one in every 770 babies born in the Unites States every year were born with an atrial septal defect.
The structural heart devices market is anticipated to record a CAGR of around 9.5% over the forecast period, i.e., 2019-2027. The market is segmented by product, by procedure, by indication and by region. The product segment is further divided into heart valves, occluders, annuloplasty rings, accessories and others, out of which, the heart valves segment is anticipated to hold the largest share in the structural heart devices market on account of rising number of procedures for trans-catheter aortic valve replacement. The heart valves consist of two types of valves, mainly surgical heart valves and trans-catheter heart valves. Along with the flourishing demand for heart valve devices, the growing approvals of these devices by the regulatory authorities is another factor estimated to result in the growth of this segment during this period. CLICK TO DOWNLOAD SAMPLE REPORT
On the basis of procedure, the market is bifurcated into repair and replacement, out of which, the replacement procedure segment is predicted to observe the highest growth on account of increasing demand for trans-catheter replacement procedures.
According to the CDC, congenital heart diseases affect around 1% births per year in the United States, which is approximately 40,000 births. The growing incidences of structural heart diseases among people, including congenital heart defects, are estimated to increase the demand for advanced treatment methods. This is anticipated to drive the market growth over the forecast period.
The development of new and innovative devices for the treatment of structural heart diseases such as annuloplasty rings and occluders is another factor anticipated to contribute towards the market growth. Rising healthcare expenditure in various countries across the world leads to a higher demand for improved products which are highly effective and last a longer time.
The treatment for structural heart diseases requires surgery which can be a highly costly procedure. Moreover, the devices with new and improved technology are expensive as well. This is predicted to lead to lower adoption of such devices in future. The rising cost of medical devices plays a major role in restricting the growth of the structural heart devices market. Furthermore, the strict government policies regarding the safety and approval of these devices is estimated to limit the growth of structural heart devices market over the forecast period.
Our in-depth analysis of the structural heart devices market includes the following segments:
On the basis of regional analysis, the structural heart devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
The largest share in structural heart devices market is anticipated to be held by the market in North America. The growing number of surgical procedures involving the heart along with rising advancements in medical technology and increasing healthcare expenditure are some factors estimated to be responsible for the market growth in this region. Moreover, the market in Europe is predicted to hold the second largest share on account of increasing elderly population as well as heart related disorders which results in a high demand for structural heart devices in the region, mainly in countries such as Germany. The fastest growing market is anticipated to be the market in Asia Pacific region on account of the large population and unhealthy lifestyle in Asian countries including China and India.
The structural heart devices market is further classified on the basis of region as follows: